AEMD
- Aethlon Medical, Inc.
()
Overview
Company Summary
Aethlon Medical, Inc. (AEMD) is a company focused on advancing therapeutic technologies to combat life-threatening conditions. Their primary objective is to address unmet medical needs in areas like infectious diseases, oncology, and autoimmune disorders.
AEMD specializes in the development of medical devices and biotherapeutic products. One of their notable technologies is the Hemopurifier� system, which is designed to selectively remove harmful viruses and tumor-secreted exosomes from the bloodstream. The Hemopurifier� has been tested in various clinical studies targeting viral diseases such as HIV, hepatitis C, and Ebola, as well as in cancer-related applications.
In addition to their flagship product, AEMD is involved in the research and development of exosome-based diagnostics and therapies. By leveraging their expertise in extracellular vesicles called exosomes, they aim to harness the potential of these tiny biological particles for disease detection, monitoring, and targeted treatment.
Aethlon Medical collaborates with leading academic institutions, governmental agencies, and industry partners to further their research and clinical trials. Their goal is to bring innovative products to market that could improve patient outcomes and provide a new approach to combating life-threatening conditions.